Heavy cannabis use was linked to reduced immune activation and inflammation in HIV-positive patients on antiretroviral therapy
A study of 198 HIV-infected, antiretroviral-treated individuals found that heavy cannabis users had significantly reduced frequencies of activated T cells and inflammatory monocytes, suggesting cannabis use may have a potentially beneficial anti-inflammatory effect in the context of treated HIV infection.
Quick Facts
What This Study Found
Researchers measured immune cell activation in 198 HIV-positive individuals on antiretroviral therapy, categorized by cannabis use level based on plasma THC metabolite concentration.
Heavy cannabis users had significantly decreased frequencies of activated (HLA-DR+CD38+) CD4+ and CD8+ T cells compared to non-users.
Heavy users also had decreased frequencies of intermediate and nonclassical monocyte subsets (inflammatory monocyte types).
Additionally, heavy cannabis users had reduced frequencies of antigen-presenting cells producing interleukin-23 and TNF-α, two pro-inflammatory cytokines.
The authors noted that while clinical implications are unclear, these findings suggest cannabis use is associated with a "potentially beneficial reduction in systemic inflammation and immune activation" in the context of treated HIV.
Key Numbers
198 HIV-positive individuals on ART. Heavy cannabis users had decreased HLA-DR+CD38+ CD4+ and CD8+ T cells, decreased intermediate and nonclassical monocytes, and decreased IL-23 and TNF-α-producing antigen-presenting cells.
How They Did This
Cross-sectional study of 198 HIV-infected, ART-treated individuals. Cannabis use categorized by plasma THC-COOH levels via mass spectrometry (heavy, medium, occasional, non-user). Immune cell phenotyping by flow cytometry.
Why This Research Matters
Chronic immune activation persists in HIV-positive patients even on effective antiretroviral therapy and drives many non-AIDS complications. If cannabis reduces this activation, it could have therapeutic implications for the large number of HIV-positive individuals who already use cannabis.
The Bigger Picture
HIV-related inflammation drives cardiovascular disease, neurodegeneration, and other complications even in virally suppressed patients. The finding that cannabis may reduce this inflammation is intriguing, though the clinical significance remains to be determined.
What This Study Doesn't Tell Us
Cross-sectional design cannot determine causation. Heavy cannabis users may differ from non-users in ways not measured. Reduced immune activation could theoretically impair needed immune responses. Clinical outcomes (disease progression, infections) were not assessed.
Questions This Raises
- ?Does reduced immune activation in cannabis-using HIV patients translate to better clinical outcomes?
- ?Could cannabis be used therapeutically to reduce HIV-associated inflammation?
- ?Does the anti-inflammatory effect come at the cost of impaired immune defense?
Trust & Context
- Key Stat:
- Heavy cannabis users had reduced activated T cells and inflammatory monocytes in treated HIV
- Evidence Grade:
- Moderate. Objective biomarker-based cannabis categorization and comprehensive immune phenotyping, but cross-sectional design limits causal conclusions.
- Study Age:
- Published in 2018. Research on cannabis and HIV-related immune activation has continued to develop.
- Original Title:
- Heavy Cannabis Use Associated With Reduction in Activated and Inflammatory Immune Cell Frequencies in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Individuals.
- Published In:
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 66(12), 1872-1882 (2018)
- Authors:
- Manuzak, Jennifer A(2), Gott, Toni M, Kirkwood, Jay S, Coronado, Ernesto, Hensley-McBain, Tiffany, Miller, Charlene, Cheu, Ryan K, Collier, Ann C, Funderburg, Nicholas T, Martin, Jeffery N, Wu, Michael C, Isoherranen, Nina, Hunt, Peter W, Klatt, Nichole R
- Database ID:
- RTHC-01746
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
Why do HIV patients have chronic inflammation even on treatment?
Antiretroviral therapy suppresses HIV replication but does not fully restore the immune system. Residual viral reservoirs, gut barrier damage, and microbial translocation contribute to persistent immune activation that drives complications like heart disease and neurodegeneration.
Does this mean HIV patients should use cannabis?
This study shows an association between heavy cannabis use and reduced immune activation, but it does not establish that cannabis caused the reduction or that it leads to better health outcomes. Clinical trials would be needed before making any therapeutic recommendations.
Read More on RethinkTHC
- 420-sober-survival-guide
- CBD-oil-quality-guide
- CBT-cannabis-recovery
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cannabis-relapse-cycle-pattern
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- cold-turkey-vs-taper-quit-weed
- dating-sober-after-quitting-weed
- exercise-quitting-weed-anxiety-brain
- grieving-quitting-weed-loss
- help-someone-quit-weed
- how-to-quit-weed
- journaling-weed-withdrawal
- marijuana-anonymous-SMART-recovery-compare
- medical-benefits-of-cannabis
- meditation-mindfulness-weed-withdrawal
- partner-still-smokes-weed
- partner-still-smokes-weed-quitting
- pink-cloud-sobriety-cannabis
- quit-weed-cold-turkey
- quit-weed-or-cut-back-which-is-better
- quit-weed-regret-went-back
- quitting-weed-20s
- quitting-weed-30s
- quitting-weed-after-years
- quitting-weed-before-surgery
- quitting-weed-during-crisis-divorce-job-loss
- quitting-weed-exercise
- quitting-weed-grief-loss-coping
- quitting-weed-legal-state
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- quitting-weed-success-stories
- quitting-weed-triggers-environment
- relapsed-smoking-weed-what-to-do
- relapsed-weed
- seniors-older-adults-cannabis-risks-medications
- should-i-quit-weed
- sober-music-festival-concert-without-weed
- supplements-weed-withdrawal
- telling-friends-quitting-weed
- weed-breastfeeding-THC-breast-milk
- weed-relapse-prevention-plan
- weed-relapse-why-it-happens
- weed-ritual-replacement
- weed-ruined-relationships
- weed-social-media-triggers-quit
Cite This Study
https://rethinkthc.com/research/RTHC-01746APA
Manuzak, Jennifer A; Gott, Toni M; Kirkwood, Jay S; Coronado, Ernesto; Hensley-McBain, Tiffany; Miller, Charlene; Cheu, Ryan K; Collier, Ann C; Funderburg, Nicholas T; Martin, Jeffery N; Wu, Michael C; Isoherranen, Nina; Hunt, Peter W; Klatt, Nichole R. (2018). Heavy Cannabis Use Associated With Reduction in Activated and Inflammatory Immune Cell Frequencies in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Individuals.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 66(12), 1872-1882. https://doi.org/10.1093/cid/cix1116
MLA
Manuzak, Jennifer A, et al. "Heavy Cannabis Use Associated With Reduction in Activated and Inflammatory Immune Cell Frequencies in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Individuals.." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018. https://doi.org/10.1093/cid/cix1116
RethinkTHC
RethinkTHC Research Database. "Heavy Cannabis Use Associated With Reduction in Activated an..." RTHC-01746. Retrieved from https://rethinkthc.com/research/manuzak-2018-heavy-cannabis-use-associated
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.